Expressionsanalyse von Stammzellmarkern bei Endometriose

The paper investigated the expression of stem cell markers in endometrium from healthy women versus endometriosis patients and assessed whether these markers are also present in ectopic endometriotic lesions. Using LSAB-based immunohistochemistry on histologic material from different lesion locations (vagina, bowel, ovary, peritoneum; n=65 preparations) and endometrial biopsies (19 controls, 19 ASRM I–II°, 11 ASRM III–IV°), the authors compared marker expression across disease severities. NANOG and Klf-4 were upregulated in the ASRM III–IV group, while Oct-4 was overexpressed both in ASRM I–II and ASRM III–IV compared with controls; Musashi-1 was also upregulated in all endometriosis groups, with peritoneal lesions showing lower expression than deep infiltrating disease. The paper is centrally about endometriosis—specifically, it analyzes stem cell marker expression in eutopic and ectopic endometriotic tissues as evidence relating to the stem cell hypothesis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works